Reviewing a Peptide API Impurity Profile: What Procurement and QA Should Ask

An impurity profile tells you how well a supplier understands its peptide API, and how to review a peptide API impurity profile from a supplier is a skill worth building in procurement and QA. Begin with the specification: which impurities are controlled, at what limits, and on what basis. Ask for the list of specified, unspecified, and total impurities, and confirm whether limits are justified by batch history, toxicology, or regulatory guidance. A profile that lists only purity by area percent is incomplete.

Request the analytical method and its validation summary. Related substances methods for peptides often rely on gradient HPLC, and the gradient, column, detection wavelength, and sample preparation all affect what is seen. Check whether the method was validated for specificity, linearity, accuracy, precision, and limits of detection and quantitation. Ask whether forced degradation studies were performed to show the method can separate degradation products from the parent peptide.

Review the forced degradation data. Stress conditions such as acid, base, oxidation, heat, and light should generate degradation products that the method resolves. If the supplier cannot show that degradants are separated, the impurity profile may understate reality. Ask for representative chromatograms from stressed samples and confirm that peak purity or orthogonal detection was used where co-elution is possible.

Look at how impurities are identified. Some related substances are known process impurities, such as truncated or deleted sequences, while others are degradation products. Ask whether the supplier has characterized major impurities by mass spectrometry or amino acid analysis. Identification is not always required, but knowing which peaks are understood helps you judge control strategy. Request the impurity naming convention so reports are comparable across lots.

Compare the profile across batches. A single lot certificate does not show consistency. Ask for a trend summary of impurity results over recent batches, including maximum values and any out-of-trend events. If an impurity approaches its limit, ask about the control strategy and whether process changes are planned. Trending data also helps you set sensible internal acceptance criteria and plan your own testing.

Consider the peptide-specific impurities. Sequence-related impurities, diastereomers, and residual counterions can be difficult to detect. Ask how the supplier controls epimerization and whether chiral methods are used where relevant. For synthetic peptides, residual solvents and reagents are separate from related substances, but both belong in your overall impurity assessment. Confirm that the certificate of analysis references the methods actually used.